Article info
PDFNeuropsychiatry
Original research
Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials
- Correspondence to Professor Zhouping Tang, Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China; ddjtzp{at}163.com; Dr Yingxin Tang; yingxintang{at}foxmail.com
Citation
Efficacy and safety of anti-inflammatory agents for the treatment of major depressive disorder: a systematic review and meta-analysis of randomised controlled trials
Publication history
- Received March 31, 2019
- Revised July 2, 2019
- Accepted August 14, 2019
- First published October 28, 2019.
Online issue publication
June 29, 2021
Article Versions
- Previous version (17 December 2019).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2020. No commercial re-use. See rights and permissions. Published by BMJ.